CClinicalTrials.gg
CompletedNCT03853408Updated Feb 25, 2019

Short Term Outcomes of Acute Cholecystitis Managed at a University Hospital

An observational study in Acute Cholecystitis, sponsored by King Abdulaziz University. Completed at 1 site in Saudi Arabia. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-02-25.

Sponsored by King Abdulaziz University · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
88
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The aim of this retrospective study was to assess the different outcomes of early (performed on the patient's first admission for acute cholecystitis) and delayed cholecystectomy (done on a second admission) at King Abdulaziz University Hospital in Jeddah, Saudi Arabia.

Read the detailed description

This study was conducted retrospectively through reviewing patients medical records

02

Conditions studied

  • Acute Cholecystitis

Keywords

  • Acute cholecystitis
  • Cholecystectomy
  • overweight
  • BMI
  • early
  • delayed
03

In context

Cholecystitis

266 studies on the registry are indexed under Cholecystitis; 46 are open to participants now.

This study's enrollment of 88 is below the median of 200 across 90 observational studies indexed under Cholecystitis.

Browse Cholecystitis studies →

Lead sponsor

King Abdulaziz University is the lead sponsor of 96 studies on the registry; 18 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The data were collected retrospectively from the electronic medical records data system at KAUH. We included all adult patients who presented to the Emergency Department of KAUH with an acute cholecystitis between January 2010 and April 2018

Inclusion criteria

Male and female patients who presented to the Emergency Department of KAUH with an acute cholecystitis

Exclusion criteria

Exclusion Criteria:

  • Patients with no acute cholecystitis
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
88 participants (actual)
Patient registry
No

Groups and cohorts

  • First Admission

    Cholecystectomy during first admission

    Procedure: Cholecystectomy

  • Second Admission

    Cholecystectomy during second admission

    Procedure: Cholecystectomy

Interventions

  • ProcedureCholecystectomy

    Cholecystectomy (removal of the gallbladder) for acute cholecystitis

06

What researchers measure

Primary outcomes

  1. Type of surgery

    Laparoscopic cholecystectomy or Laparoscopic cholecystectomy converted to open

    Time frame: Intraoperative (during surgery) - surgery takes an hour on an average

  2. Blood Transfusion need

    * Yes * No

    Time frame: Intraoperative (during surgery) - surgery takes an hour on an average

  3. ICU admission:

    * Yes * No

    Time frame: Post operation "after surgery" immediately

  4. Duration of Surgery

    How many minutes did the surgery take (range)

    Time frame: minutes "intraoperative" (surgery takes 1 hour on an average)

  5. Time to operation room (hours)

    How many hours from admission to surgery

    Time frame: hours pre surgery

  6. Length of stay after surgery

    How many days did patients stay after surgery (range)

    Time frame: Days ( usually 2 days on an average )

07

Study locations

1 site
  • King Abulaziz University
    Jeddah, Makkah Region 23534, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: Undecided — The datasets generated and analyzed during this study are available upon request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03853408
Lead sponsor
King Abdulaziz University
Responsible party
Munirah Fetaini (Principal Investigator, King Abdulaziz University) — Principal investigator
First posted
Feb 25, 2019
Start date
Jul 26, 2017
Primary completion
Sep 14, 2018
Completion
Nov 29, 2018
Last update
Feb 25, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion